Is age associated with the number or types of medications prescribed to renal transplant recipients?

Marie A. Chisholm, Joel Melroy, Maribeth H Johnson, Laura L Mulloy, Christina A. Spivey

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

OBJECTIVES: To determine whether age influences the number or types of medications prescribed to younger (aged 18-64) and elderly (aged ≥65) renal transplant recipients 3 years posttransplant. DESIGN: A cross-sectional study involving renal transplant recipients. SETTING: Medical College of Georgia. PARTICIPANTS: A random sample of 100 elderly and 100 younger renal transplant recipients who received posttransplant care at the Medical College of Georgia, were on stable immunosuppressant therapy regimens, and were at least 3 years posttransplant. MEASUREMENTS: Medical and pharmacy data of recipients were evaluated for demographics; presence of a lipid-lowering agent; number of antihypertensives, immunosuppressants, antidiabetic agents, and total medications; number of rejections; dose per kilogram of immunosuppressant(s); infection-related hospitalizations; and measures of blood pressure, blood glucose, serum creatinine, serum tacrolimus/cyclosporine concentrations, total cholesterol, and triglycerides. RESULTS: Elderly recipients were more likely to have diabetes mellitus before the transplant and to develop diabetes mellitus afterwards (P=.04) and were prescribed more total medications (12.40±3.72 vs 10.25±4.07, P<.001) and antidiabetic agents (0.89±0.93 vs 0.42±0.77, P<.001) 3 years posttransplant than younger recipients. Elderly recipients also had fewer chronic rejections, more infection-related hospitalizations, lower diastolic blood pressure, and greater fasting blood glucose levels 3 years posttransplant (P<.05) than younger recipients. CONCLUSION: Future investigation should focus on deciphering the implications of the greater numbers of medications prescribed to elderly renal transplant recipients in terms of maximizing desired health outcomes (e.g., graft survival) and minimizing adverse drug-related experiences (e.g., infection).

Original languageEnglish (US)
Pages (from-to)389-394
Number of pages6
JournalJournal of the American Geriatrics Society
Volume55
Issue number3
DOIs
StatePublished - Jan 1 2007

Fingerprint

Kidney
Immunosuppressive Agents
Blood Pressure
Hypoglycemic Agents
Blood Glucose
Diabetes Mellitus
Hospitalization
Infection
Tacrolimus
Graft Survival
Serum
Antihypertensive Agents
Cyclosporine
Fasting
Creatinine
Triglycerides
Cross-Sectional Studies
Cholesterol
Demography
Transplant Recipients

Keywords

  • Aging
  • Medication regimens
  • Renal transplantation

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Is age associated with the number or types of medications prescribed to renal transplant recipients? / Chisholm, Marie A.; Melroy, Joel; Johnson, Maribeth H; Mulloy, Laura L; Spivey, Christina A.

In: Journal of the American Geriatrics Society, Vol. 55, No. 3, 01.01.2007, p. 389-394.

Research output: Contribution to journalArticle

@article{72e19bf5d12347e89a0482ae21ea8b59,
title = "Is age associated with the number or types of medications prescribed to renal transplant recipients?",
abstract = "OBJECTIVES: To determine whether age influences the number or types of medications prescribed to younger (aged 18-64) and elderly (aged ≥65) renal transplant recipients 3 years posttransplant. DESIGN: A cross-sectional study involving renal transplant recipients. SETTING: Medical College of Georgia. PARTICIPANTS: A random sample of 100 elderly and 100 younger renal transplant recipients who received posttransplant care at the Medical College of Georgia, were on stable immunosuppressant therapy regimens, and were at least 3 years posttransplant. MEASUREMENTS: Medical and pharmacy data of recipients were evaluated for demographics; presence of a lipid-lowering agent; number of antihypertensives, immunosuppressants, antidiabetic agents, and total medications; number of rejections; dose per kilogram of immunosuppressant(s); infection-related hospitalizations; and measures of blood pressure, blood glucose, serum creatinine, serum tacrolimus/cyclosporine concentrations, total cholesterol, and triglycerides. RESULTS: Elderly recipients were more likely to have diabetes mellitus before the transplant and to develop diabetes mellitus afterwards (P=.04) and were prescribed more total medications (12.40±3.72 vs 10.25±4.07, P<.001) and antidiabetic agents (0.89±0.93 vs 0.42±0.77, P<.001) 3 years posttransplant than younger recipients. Elderly recipients also had fewer chronic rejections, more infection-related hospitalizations, lower diastolic blood pressure, and greater fasting blood glucose levels 3 years posttransplant (P<.05) than younger recipients. CONCLUSION: Future investigation should focus on deciphering the implications of the greater numbers of medications prescribed to elderly renal transplant recipients in terms of maximizing desired health outcomes (e.g., graft survival) and minimizing adverse drug-related experiences (e.g., infection).",
keywords = "Aging, Medication regimens, Renal transplantation",
author = "Chisholm, {Marie A.} and Joel Melroy and Johnson, {Maribeth H} and Mulloy, {Laura L} and Spivey, {Christina A.}",
year = "2007",
month = "1",
day = "1",
doi = "10.1111/j.1532-5415.2007.01077.x",
language = "English (US)",
volume = "55",
pages = "389--394",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Is age associated with the number or types of medications prescribed to renal transplant recipients?

AU - Chisholm, Marie A.

AU - Melroy, Joel

AU - Johnson, Maribeth H

AU - Mulloy, Laura L

AU - Spivey, Christina A.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - OBJECTIVES: To determine whether age influences the number or types of medications prescribed to younger (aged 18-64) and elderly (aged ≥65) renal transplant recipients 3 years posttransplant. DESIGN: A cross-sectional study involving renal transplant recipients. SETTING: Medical College of Georgia. PARTICIPANTS: A random sample of 100 elderly and 100 younger renal transplant recipients who received posttransplant care at the Medical College of Georgia, were on stable immunosuppressant therapy regimens, and were at least 3 years posttransplant. MEASUREMENTS: Medical and pharmacy data of recipients were evaluated for demographics; presence of a lipid-lowering agent; number of antihypertensives, immunosuppressants, antidiabetic agents, and total medications; number of rejections; dose per kilogram of immunosuppressant(s); infection-related hospitalizations; and measures of blood pressure, blood glucose, serum creatinine, serum tacrolimus/cyclosporine concentrations, total cholesterol, and triglycerides. RESULTS: Elderly recipients were more likely to have diabetes mellitus before the transplant and to develop diabetes mellitus afterwards (P=.04) and were prescribed more total medications (12.40±3.72 vs 10.25±4.07, P<.001) and antidiabetic agents (0.89±0.93 vs 0.42±0.77, P<.001) 3 years posttransplant than younger recipients. Elderly recipients also had fewer chronic rejections, more infection-related hospitalizations, lower diastolic blood pressure, and greater fasting blood glucose levels 3 years posttransplant (P<.05) than younger recipients. CONCLUSION: Future investigation should focus on deciphering the implications of the greater numbers of medications prescribed to elderly renal transplant recipients in terms of maximizing desired health outcomes (e.g., graft survival) and minimizing adverse drug-related experiences (e.g., infection).

AB - OBJECTIVES: To determine whether age influences the number or types of medications prescribed to younger (aged 18-64) and elderly (aged ≥65) renal transplant recipients 3 years posttransplant. DESIGN: A cross-sectional study involving renal transplant recipients. SETTING: Medical College of Georgia. PARTICIPANTS: A random sample of 100 elderly and 100 younger renal transplant recipients who received posttransplant care at the Medical College of Georgia, were on stable immunosuppressant therapy regimens, and were at least 3 years posttransplant. MEASUREMENTS: Medical and pharmacy data of recipients were evaluated for demographics; presence of a lipid-lowering agent; number of antihypertensives, immunosuppressants, antidiabetic agents, and total medications; number of rejections; dose per kilogram of immunosuppressant(s); infection-related hospitalizations; and measures of blood pressure, blood glucose, serum creatinine, serum tacrolimus/cyclosporine concentrations, total cholesterol, and triglycerides. RESULTS: Elderly recipients were more likely to have diabetes mellitus before the transplant and to develop diabetes mellitus afterwards (P=.04) and were prescribed more total medications (12.40±3.72 vs 10.25±4.07, P<.001) and antidiabetic agents (0.89±0.93 vs 0.42±0.77, P<.001) 3 years posttransplant than younger recipients. Elderly recipients also had fewer chronic rejections, more infection-related hospitalizations, lower diastolic blood pressure, and greater fasting blood glucose levels 3 years posttransplant (P<.05) than younger recipients. CONCLUSION: Future investigation should focus on deciphering the implications of the greater numbers of medications prescribed to elderly renal transplant recipients in terms of maximizing desired health outcomes (e.g., graft survival) and minimizing adverse drug-related experiences (e.g., infection).

KW - Aging

KW - Medication regimens

KW - Renal transplantation

UR - http://www.scopus.com/inward/record.url?scp=33847295210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847295210&partnerID=8YFLogxK

U2 - 10.1111/j.1532-5415.2007.01077.x

DO - 10.1111/j.1532-5415.2007.01077.x

M3 - Article

C2 - 17341241

AN - SCOPUS:33847295210

VL - 55

SP - 389

EP - 394

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 3

ER -